A Phase 2 Study of Vapendavir in Asthmatic Adults With Symptomatic Human Rhinovirus Infection

Condition:   Asthma
Interventions:   Drug: Vapendavir;   Drug: Vapendavir;   Drug: Placebo
Sponsor:   Biota Pharmaceuticals, Inc.
Recruiting – verified February 2015

View full post on ClinicalTrials.gov: asthma | received in the last 14 days